Phytoneering in clinical practice
- Authors: Tsukanov A.I.1, Matveev E.V.1
-
Affiliations:
- Omsk State Medical University
- Issue: Vol 23, No 12 (2021)
- Pages: 977-980
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/100036
- DOI: https://doi.org/10.26442/20751753.2021.12.201328
- ID: 100036
Cite item
Full Text
Abstract
The discovery of antibiotics almost 100 years ago seemed to have forever solved the issue of treating infectious diseases for humanity. However, the avalanche-like growth in antibiotic resistance requires the search for alternative methods of treatment, one of which is treatment with herbal products created according to the phytoneering concept. It is a technology that combines the enormous potential of medicinal plants (phyto) with the knowledge and methodology of modern pharmaceutical research (engineering). The article presents 2 clinical cases of the use of the herbal product Canephron N for the prevention of cystitis and acute urolithiasis – common disorders in the practice of a urologist.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Anton Iu. Tsukanov
Omsk State Medical University
Author for correspondence.
Email: autt@mail.ru
D. Sci. (Med.), Prof.
Russian Federation, OmskEvgenii V. Matveev
Omsk State Medical University
Email: autt@mail.ru
Cand. Sci. (Med.)
Russian Federation, OmskReferences
- Кульчавеня Е.В., Неймарк А.И., Цуканов А.Ю., Ярин Г.Ю. Современные подходы к диагностике острого цистита и оценке качества его лечения. Урология. 2020;3:22-5 [Kul'chavenia EV, Neimark AI, Tsukanov AIu, Iarin GIu. Sovremennye podkhody k diagnostike ostrogo tsistita i otsenke kachestva ego lecheniia. Urologiia. 2020;3:22-5 (in Russian)].
- Синякова Л.А. Инфекции нижних мочевыводящих путей у женщин –проблемы и ошибки. Урология. 2021;1:140-5 [Siniakova LA. Infektsii nizhnikh mochevyvodiashchikh putei u zhenshchin – problemy i oshibki. Urologiia. 2021;1:140-5 (in Russian)].
- Цистит у женщин. Клинические рекомендации РОУ, 2021 [Tsistit u zhenshchin. Klinicheskie rekomendatsii ROU, 2021 (in Russian)].
- Синякова Л.А. Профилактика рецидивирующих инфекций нижних мочевых путей. Consilium Medicum. 2013;15(6):44-6 [Sinyakova LA. Prevention of recurrent lower urinary tract infections. Consilium Medicum. 2013;15(6):44-6 (in Russian)].
- Палагин И.С., Сухорукова М.В., Дехнич А.В., и др. Состояние антибиотикорезистентности возбудителей внебольничных инфекций мочевыводящих путей в России, Беларуси и Казахстане: результаты многоцентрового международного исследования «Дармис-2018». Урология. 2020;1:19-31 [Palagin IS, Sukhorukova MV, Dekhnich AV, et al. Sostoianie antibiotikorezistentnosti vozbuditelei vnebol'nichnykh infektsii mochevyvodiashchikh putei v Rossii, Belarusi i Kazakhstane: rezul'taty mnogotsentrovogo mezhdunarodnogo issledovaniia “Darmis-2018”. Urologiia. 2020;1:19-31 (in Russian)].
- Ivanov D, Abramov-Sommariva D, Moritz K, et al. An open label, noncontrolled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the managementof uncomplicated urinary tract infections (uUTIs). Clin Phytosci. 2015;1(7):1-11. doi: 10.1186/s40816–015–0008-x
- Wagenlehner FM, Abramov-Sommariva D, Höller M, et al. Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections in Women: A Double-Blind, Parallel-Group, Randomized, Multicentre, Non-Inferiority Phase III Trial. Urol Int. 2018;101(3):327-36. doi: 10.1159/000493368
- Ny S, Edquist P, Dumpis U, et al. Antibiotic resistance of Escherichia coli from outpatient urinary tract infection in women in six European countries including Russia. J Glob Antimicrob Resist. 2019;17:25-34. doi: 10.1016/j.jgar.2018.11.004
- Höller M, Steindl H, Abramov-Sommariva D, et al. Treatment of Urinary Tract Infections with Canephron® in Germany: A Retrospective Database Analysis. Antibiotics (Basel). 2021;10(6):685. doi: 10.3390/antibiotics10060685
- Naber KG. Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia. Res Rep Urol. 2013;5:39-46. doi: 10.2147/RRU.S39288
- Аляев Ю.Г., Амосов А.В., Григорян В.А., и др. Применение растительного препарата Канефрона®Н у больных с хроническим циститом и мочекаменной болезнью. Урология. 2005;4:29-33 [Aliaev IuG, Amosov AV, Grigorian VA, et al. Primenenie rastitel'nogo preparata Kanefrona®N u bol'nykh s khronicheskim tsistitom i mochekamennoi bolezn'iu. Urologiia. 2005;4:29-33 (in Russian)].
- Shoag J, Tasian GE, Goldfarb DS, Eisner BH. The new epidemiology of nephrolithiasis. Adv Chronic Kidney Dis. 2015;22(4):273-8. doi: 10.1053/j.ackd.2015.04.004
- Sakhaee K, Maalouf NM, Sinnott B. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab. 2012;97(6):1847-60. doi: 10.1210/jc.2011-3492
- Капсаргин Ф.П., Саенко В.С., Трояков В.М., и др. Роль растительных препаратов в литокинетической терапии и метафилактике мочекаменной болезни. Экспериментальная и клиническая урология. 2021;14(2):92-98 [Kapsargin FP, Saenko VS, Troiakov VM, et al. Rol' rastitel'nykh preparatov v litokineticheskoi terapii i metafilaktike mochekamennoi bolezni. Eksperimental'naia i klinicheskaia urologiia. 2021;14(2):92-98 (in Russian)].
- Амосов А.В. Растительный препарат Канефрон в урологической практике. Врач. 2000;6:36 [Amosov AV. Rastitel'nyi preparat Kanefron v urologicheskoi praktike. Vrach. 2000;6:36 (in Russian)].
- Григорян В.А., Амосов А.В., Султанова Е.А., и др. Применение Канефрона®Н при мочекаменной болезни. РМЖ. Урология. 2001;19(17):1113-6 [Grigorian VA, Amosov AV, Sultanova EA, et al. Primenenie Kanefrona®N pri mochekamennoi bolezni. RMZh. Urologiia. 2001;19(17):1113-6 (in Russian)].
Supplementary files
